Evaluation of function for ligands of activating natural killer cells receptors in anti-tumor immunity
Number of publications: 8
Israeli Partner: A. Porgador, Ben-Gurion Univ.
German Partner: A. Cerwenka, DKFZ
Publications
| Publication |
|---|
| Publication |
|
Arnon, T. I., Markel, G., Bar-Ilan, A., Hanna, J., Fima, E., Benchetrit, F., Galili, R., Cerwenka, A., Benharroch, D., Sion-Vardy, N., Porgador, A., Mandelboim, O.
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy 3 (5), PLoS One, e2150, 2008 |
|
Elkabets, M., Krelin, Y., Dotan, S., Cerwenka, A., Porgador, A., Lichtenstein, R. G., White, M. R., Zoller, M., Iwakura, Y., Dinarello, C. A., Voronov, E., Apte, R. N.
Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells 182 (8), J Immunol, 4874-81, 2009 |
|
Hecht, M. L., Rosental, B., Horlacher, T., Hershkovitz, O., De Paz, J. L., Noti, C., Schauer, S., Porgador, A., Seeberger, P. H.
Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences 8 (2), J Proteome Res, 712-20, 2009 |
|
Hershkovitz, O., Jarahian, M., Zilka, A., Bar-Ilan, A., Landau, G., Jivov, S., Tekoah, Y., Glicklis, R., Gallagher, J. T., Hoffmann, S. C., Zer, H., Mandelboim, O., Watzl, C., Momburg, F., Porgador, A.
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool 18 (1), Glycobiology, 28-41, 2008 |
|
Hershkovitz, O., Jivov, S., Bloushtain, N., Zilka, A., Landau, G., Bar-Ilan, A., Lichtenstein, R. G., Campbell, K. S., van Kuppevelt, T. H., Porgador, A.
Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44 46 (25), Biochemistry, 7426-36, 2007 |
|
Nausch, N., Cerwenka, A.
NKG2D ligands in tumor immunity 27 (45), Oncogene, 5944-58, 2008 |
|
Textor, S., Durst, M., Jansen, L., Accardi, R., Tommasino, M., Trunk, M. J., Porgador, A., Watzl, C., Gissmann, L., Cerwenka, A.
Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer 123 (10), Int J Cancer, 2343-53, 2008 |
|
Zilka, A., Landau, G., Hershkovitz, O., Bloushtain, N., Bar-Ilan, A., Benchetrit, F., Fima, E., van Kuppevelt, T. H., Gallagher, J. T., Elgavish, S., Porgador, A.
Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46 44 (44), Biochemistry, 14477-85, 2005 |